For a drug to be approved for the pregnant population, it must go through rigorous testing with that population, and that has not yet happened for semaglutide or other GLP-1 (glucagon-like peptide 1) agonists, says Carrie Burns , MD, a board-certified endocrinologist and director of diabetes in pregnancy at Penn Medicine in Philadelphia
David Lau, a professor emeritus of medicine, biochemistry and molecular biology at the University of Calgary, is intrigued by this strategy as well
It often means they have not invested in the extended stability testing required to justify longer dating
After a dose, the medication turns down food noise, the constant background hum of hunger, while simultaneously turning up your fullness, so even a small amount of food leaves you surprisingly full
It is a logical continuation of the dual-agonist story for investigators tracking this field
You have less caloric fuel